Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation
Crossref DOI link: https://doi.org/10.1038/s41598-017-14858-z
Published Online: 2017-11-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hu, Chao
Yu, Mengxia
Ren, Yanling
Li, Kongfei
Maggio, Dominic M.
Mei, Chen
Ye, Li
Wei, Juying
Jin, Jie
Zhuang, Zhengping
Tong, Hongyan
Text and Data Mining valid from 2017-11-07
Version of Record valid from 2017-11-07
Article History
First Online: 7 November 2017